Indefinite Delivery Contract 36C26122D0016

Award Date 10/1/21
Last Date to Order 9/30/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 (VA-VHA) awarded Diasorin Inc. an Indefinite Delivery Contract with a potential value of $2,460,527.50 to provide Diasorin reagents and Liaison XL analyzers. The contract is a single award with no set-aside and orders can be placed through September 2024. Under the contract, Diasorin has received five firm fixed price delivery orders to date for reagents and analyzers, all with performance...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a single-award Indefinite Delivery Contract (IDC) to Diasorin Molecular LLC, a foreign-owned medical diagnostics manufacturer, to provide COVID-19 tests, analyzers, and related laboratory equipment. The $10 million IDC, issued through VA's Veterans Integrated Service Network (VISN) 23, has an ultimate completion date of September 30, 2026. Under this IDC, Diasorin Molecular has received numerous firm-fixed price...
The subject contract is an Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit manufacturer of diagnostic testing equipment, assays, reagents, and related services. The contract has a total ceiling value of $291,245.30 and a period of performance through July 14, 2025. Under this IDC, Diasorin will provide the VA's VISN 17 network with its LIAISON XL analyzer reagents for a variety of infectious disease testing,...
Diasorin Inc. was awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 to provide consumable reagents and supplies for Liaison XL instruments. The contract has a potential value of $226K and a period of performance from August 2022 through July 2027. No set-aside designation was used. Under the contract, Diasorin received two delivery orders to date for laboratory locations in Stillwater, Minnesota and...
This federal contract IDV award was issued by the Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company, with Diasorin S.P.A. as the parent company. The single-award, firm-fixed-price indefinite-delivery/indefinite-quantity (IDIQ) contract, valued at $1,754,335.20, is for the lease of Liaison XL analyzers, installation, training, preventative maintenance, services/repairs, and associated reagents, consumables, and supplies for VA medical...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded Diasorin Inc. a single award indefinite delivery contract to provide immunoassay testing supplies. The contract has a potential value of $1,397,135.10 and a period of performance through May 7, 2025. No set-aside provisions were applied. Delivery orders issued against this contract include $125,000 for supplies through May 24, 2024; $106,031.01 for supplies through May 7, 2025; $87,248...
The federal contract IDV award to Diasorin Inc., a foreign-owned for-profit medical diagnostics company, is a $10 million Federal Supply Schedule (FSS) contract from the Department of Veterans Affairs (VA). The contract, with a period of performance through March 2030, is for the provision of cost-per-test clinical laboratory analyzers and associated services. Diasorin Inc. is the prime contractor, with its parent company Diasorin S.P.A. providing overall corporate support. The contract provides...
This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 23 to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The single-award IDV, valued at $750,000, provides the VA with access to Diasorin's advanced chemiluminescence immunoassay diagnostic testing equipment, assays, reagents, and associated technical services. Task orders issued under this IDV, valued between $2,044.62...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded an indefinite delivery contract to Diasorin Molecular LLC with a potential value of $7,000,000.00 to procure real-time polymerase chain reaction instrumentation for COVID-19 and influenza testing. No set-aside provisions were applied to the single award contract. The originating solicitation sought one-year polymerase chain reaction instrumentation for COVID and influenza testing,...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company, for the supply of reagents, automated diagnostic testing equipment, and related services. The single-award contract has a ceiling value of $321,055.77 and a period of performance through September 30, 2025. Diasorin Inc. is a subsidiary of the parent company Diasorin S.P.A., which has an extensive track record as a federal contractor,...
  • 36C26122D0016
    Indefinite Delivery Contract
  • 4
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite-delivery, indefinite-quantity contract to Diasorin Inc. to provide diagnostic testing services and related equipment. The contract has a potential value of $2,000,000 and period of performance from October 1, 2021 through September 30, 2026. Delivery orders issued against the contract include diagnostic testing for procalcitonin, vitamin D, tuberculosis, and COVID-19 at VA facilities in North Las Vegas, Nevada and Cypress, California. Tests will be performed using Diasorin's Liaison XL Analyzer on a firm-fixed price basis.

The original pre-solicitation notice indicated the agency's intent to award a single-source IDIQ to Diasorin as the only provider that could meet its requirement for the specialized Liaison XL Analyzer and FDA-approved assays compatible with its laboratory capabilities and Clinical Laboratory Improvement Amendments program. No responsible alternative sources were identified in response to the notice. The contract aims to efficiently meet the diagnostic testing needs of veterans through the VA's healthcare programs using existing laboratory equipment and assays.

Generated 1/5/24, 12:50 AM